1. Home
  2. NBIX vs TLN Comparison

NBIX vs TLN Comparison

Compare NBIX & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.61

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

TLN

Talen Energy Corporation

HOLD

Current Price

$345.08

Market Cap

14.2B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
TLN
Founded
1992
2015
Country
United States
United States
Employees
N/A
1880
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
14.2B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
TLN
Price
$130.61
$345.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
12
Target Price
$180.82
$433.50
AVG Volume (30 Days)
901.1K
615.1K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$22.85
$85.30
Revenue Next Year
$10.36
$10.97
P/E Ratio
$27.09
$83.51
Revenue Growth
977.51
N/A
52 Week Low
$97.30
$186.55
52 Week High
$160.18
$451.28

Technical Indicators

Market Signals
Indicator
NBIX
TLN
Relative Strength Index (RSI) 50.14 56.82
Support Level $124.29 $303.75
Resistance Level $136.23 $345.29
Average True Range (ATR) 4.29 14.99
MACD -0.08 2.92
Stochastic Oscillator 59.64 94.06

Price Performance

Historical Comparison
NBIX
TLN

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About TLN Talen Energy Corporation

Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.

Share on Social Networks: